Nat. Immunol.

The mechanism by which mutations in CARD15, which encodes nucleotide-binding oligomerization domain 2 (NOD2), cause Crohn disease is poorly understood. Because signaling via mutated NOD2 proteins leads to defective activation of the transcription factor NF-kappa B, one proposal is that mutations cause deficient NF-kappa B-dependent T helper type 1 (T(H)1) responses and increased susceptibility to infection. However, this idea is inconsistent with the increased T(H)1 responses characteristic of Crohn disease. Here we used Card15(-/-) mice to show that intact NOD2 signaling inhibited Toll-like receptor 2-driven activation of NF-kappa B, particularly of the NF-kappa B subunit c-Rel. Moreover, NOD2 deficiency or the presence of a Crohn disease-like Card15 mutation increased Toll-like receptor 2-mediated activation of NF-kappa B-c-Rel, and T(H)1 responses were enhanced. Thus, CARD15 mutations may lead to disease by causing excessive T(H)1 responses.

Source:http://purl.uniprot.org/citations/15220916

Statements in which the resource exists.
SubjectPredicateObjectContext
http://purl.uniprot.org/cit...rdf:typeuniprot:Journal_Citationlld:uniprot
http://purl.uniprot.org/cit...rdfs:commentThe mechanism by which mutations in CARD15, which encodes nucleotide-binding oligomerization domain 2 (NOD2), cause Crohn disease is poorly understood. Because signaling via mutated NOD2 proteins leads to defective activation of the transcription factor NF-kappa B, one proposal is that mutations cause deficient NF-kappa B-dependent T helper type 1 (T(H)1) responses and increased susceptibility to infection. However, this idea is inconsistent with the increased T(H)1 responses characteristic of Crohn disease. Here we used Card15(-/-) mice to show that intact NOD2 signaling inhibited Toll-like receptor 2-driven activation of NF-kappa B, particularly of the NF-kappa B subunit c-Rel. Moreover, NOD2 deficiency or the presence of a Crohn disease-like Card15 mutation increased Toll-like receptor 2-mediated activation of NF-kappa B-c-Rel, and T(H)1 responses were enhanced. Thus, CARD15 mutations may lead to disease by causing excessive T(H)1 responses.lld:uniprot
http://purl.uniprot.org/cit...skos:exactMatchhttp://purl.uniprot.org/pub...lld:uniprot
http://purl.uniprot.org/cit...uniprot:nameNat. Immunol.lld:uniprot
http://purl.uniprot.org/cit...uniprot:authorWatanabe T.lld:uniprot
http://purl.uniprot.org/cit...uniprot:authorStrober W.lld:uniprot
http://purl.uniprot.org/cit...uniprot:authorMurray P.J.lld:uniprot
http://purl.uniprot.org/cit...uniprot:authorKitani A.lld:uniprot
http://purl.uniprot.org/cit...uniprot:date2004lld:uniprot
http://purl.uniprot.org/cit...uniprot:pages800-808lld:uniprot
http://purl.uniprot.org/cit...uniprot:titleNOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.lld:uniprot
http://purl.uniprot.org/cit...uniprot:volume5lld:uniprot
http://purl.uniprot.org/cit...dc-term:identifierdoi:10.1038/ni1092lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot
http://linkedlifedata.com/r...uniprot:sourcehttp://purl.uniprot.org/cit...lld:uniprot